A

AtriCure

ATRC

21.050
USD
-0.46
(-2.14%)
مغلق
حجم التداول
9,404
الربح لكل سهم
0
العائد الربحي
0
P/E
-33
حجم السوق
1,395,183,518
أصول ذات صلة
ABT
4.220
(3.98%)
110.150 USD
BSX
1.315
(1.78%)
75.170 USD
EW
-1.220
(-1.94%)
61.830 USD
ISRG
6.98
(1.57%)
451.27 USD
JNJ
2.930
(1.86%)
160.770 USD
M
MASI
0.350
(0.33%)
107.290 USD
MDT
0.160
(0.20%)
80.470 USD
P
PEN
3.960
(2.37%)
171.260 USD
SYK
5.59
(1.71%)
332.94 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
الأخبار المقالات

العنوان: AtriCure

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct salesforce and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growingtrend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.